Correction to: Tuberculosis and viral hepatitis in patients treated with certolizumab pegol in Asia-Pacific countries and worldwide: real-world and clinical trial data (Clinical Rheumatology, (2020), 10.1007/s10067-020-05248-4)

Chak Sing Lau; Yi Hsing Chen; Keith Lim; Marc de Longueville; Catherine Arendt; Kevin Winthrop

doi:10.1007/s10067-020-05356-1

Correction to: Tuberculosis and viral hepatitis in patients treated with certolizumab pegol in Asia-Pacific countries and worldwide: real-world and clinical trial data (Clinical Rheumatology, (2020), 10.1007/s10067-020-05248-4)

Chak Sing Lau, Yi Hsing Chen, Keith Lim, Marc de Longueville, Catherine Arendt, Kevin Winthrop

School Of Public Health

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The original published version of the above article contained an error.

Original language	English (US)
Pages (from-to)	3161
Number of pages	1
Journal	Clinical Rheumatology
Volume	39
Issue number	10
DOIs	https://doi.org/10.1007/s10067-020-05356-1
State	Published - Oct 1 2020

ASJC Scopus subject areas

Rheumatology

Access to Document

10.1007/s10067-020-05356-1

Fingerprint

Dive into the research topics of 'Correction to: Tuberculosis and viral hepatitis in patients treated with certolizumab pegol in Asia-Pacific countries and worldwide: real-world and clinical trial data (Clinical Rheumatology, (2020), 10.1007/s10067-020-05248-4)'. Together they form a unique fingerprint.

Cite this

Lau, C. S., Chen, Y. H., Lim, K., de Longueville, M., Arendt, C., & Winthrop, K. (2020). Correction to: Tuberculosis and viral hepatitis in patients treated with certolizumab pegol in Asia-Pacific countries and worldwide: real-world and clinical trial data (Clinical Rheumatology, (2020), 10.1007/s10067-020-05248-4). Clinical Rheumatology, 39(10), 3161. https://doi.org/10.1007/s10067-020-05356-1

Correction to: Tuberculosis and viral hepatitis in patients treated with certolizumab pegol in Asia-Pacific countries and worldwide: real-world and clinical trial data (Clinical Rheumatology, (2020), 10.1007/s10067-020-05248-4). / Lau, Chak Sing; Chen, Yi Hsing; Lim, Keith et al.
In: Clinical Rheumatology, Vol. 39, No. 10, 01.10.2020, p. 3161.

Research output: Contribution to journal › Comment/debate › peer-review

Lau, CS, Chen, YH, Lim, K, de Longueville, M, Arendt, C & Winthrop, K 2020, 'Correction to: Tuberculosis and viral hepatitis in patients treated with certolizumab pegol in Asia-Pacific countries and worldwide: real-world and clinical trial data (Clinical Rheumatology, (2020), 10.1007/s10067-020-05248-4)', Clinical Rheumatology, vol. 39, no. 10, pp. 3161. https://doi.org/10.1007/s10067-020-05356-1

Lau CS, Chen YH, Lim K, de Longueville M, Arendt C, Winthrop K. Correction to: Tuberculosis and viral hepatitis in patients treated with certolizumab pegol in Asia-Pacific countries and worldwide: real-world and clinical trial data (Clinical Rheumatology, (2020), 10.1007/s10067-020-05248-4). Clinical Rheumatology. 2020 Oct 1;39(10):3161. doi: 10.1007/s10067-020-05356-1

@article{d1abd1b9994d429ebef29b3ac80e6122,

title = "Correction to: Tuberculosis and viral hepatitis in patients treated with certolizumab pegol in Asia-Pacific countries and worldwide: real-world and clinical trial data (Clinical Rheumatology, (2020), 10.1007/s10067-020-05248-4)",

abstract = "The original published version of the above article contained an error.",

author = "Lau, {Chak Sing} and Chen, {Yi Hsing} and Keith Lim and {de Longueville}, Marc and Catherine Arendt and Kevin Winthrop",

note = "Publisher Copyright: {\textcopyright} 2020, International League of Associations for Rheumatology (ILAR).",

year = "2020",

month = oct,

day = "1",

doi = "10.1007/s10067-020-05356-1",

language = "English (US)",

volume = "39",

pages = "3161",

journal = "Clinical Rheumatology",

issn = "0770-3198",

publisher = "Springer London",

number = "10",

}

TY - JOUR

T1 - Correction to

T2 - Tuberculosis and viral hepatitis in patients treated with certolizumab pegol in Asia-Pacific countries and worldwide: real-world and clinical trial data (Clinical Rheumatology, (2020), 10.1007/s10067-020-05248-4)

AU - Lau, Chak Sing

AU - Chen, Yi Hsing

AU - Lim, Keith

AU - de Longueville, Marc

AU - Arendt, Catherine

AU - Winthrop, Kevin

PY - 2020/10/1

Y1 - 2020/10/1

N2 - The original published version of the above article contained an error.

AB - The original published version of the above article contained an error.

UR - http://www.scopus.com/inward/record.url?scp=85090115213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85090115213&partnerID=8YFLogxK

U2 - 10.1007/s10067-020-05356-1

DO - 10.1007/s10067-020-05356-1

M3 - Comment/debate

C2 - 32876785

AN - SCOPUS:85090115213

SN - 0770-3198

VL - 39

SP - 3161

JO - Clinical Rheumatology

JF - Clinical Rheumatology

IS - 10

ER -

Correction to: Tuberculosis and viral hepatitis in patients treated with certolizumab pegol in Asia-Pacific countries and worldwide: real-world and clinical trial data (Clinical Rheumatology, (2020), 10.1007/s10067-020-05248-4)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this